Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: Lapatinib plus capecitabine
Sponsor: GlaxoSmithKline